TabsDetailsBasic DetailsDate: Monday, February 20, 2017Type: PublicationDescription: This report examines ondansetron use in pregnancy in the context of other antiemetic use among a large insured United States population of women delivering live births. Read More Materials: Pharmacoepidemiology & Drug Safety; DOI:10.1002/pds.4185. [Epub ahead of print]Additional InformationRelated Assessment(s): Antiemetic Use During PregnancyContributorsAuthor(s): Lockwood G. Taylor PhD, MPH; Steven T. Bird PharmD, PhD, MS; Leyla Sahin MD; Melissa S. Tassinari PhD; Patty Greene PharmD; Marsha E. Reichman PhD; Susan E. Andrade ScD; Katherine Haffenreffer BS; Sengwee Toh ScDCorresponding Author: L. G. Taylor, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Bldg 22, Rm 2406, Silver Spring, MD 20903, USA. E-mail: lockwood.taylor@fda.hhs.gov
